GynecologyGynecology2079-56962079-5831Consilium Medicum27364Research ArticleEffektivnost' lecheniya klimaktericheskogo sindroma preparatom premarinLedinaA V-1502200131131409042020Copyright © 2001, Consilium Medicum2001[Speroff L. Postmenopausal hormone replacement therapy: some common and uncommon questions//The prescrieber’s guide to Hormone Replacement Therapy edited by M.Whitehead. Parthenon Pabl.Gr.Ltd. 1998; 41-53.][Руководство по эндокринной гинекологии//Под ред. Е.М.Вихляевой. М.: Мед. инф. Аг - во. 1997; 768 с.][Samsioe G. et al. Urogenital symptoms in women aged 50-59 years//Gyn Endocrin 1999; l3-Is 2 (2): 113-7.][Kanis J.A., Mc Closkey T.V. Risk factors in osteoporosis//Maturitas 1998; 30 (16): 229-33.][Paganini-Hill A. and Henderson V.W. Estrogen deficiency and risk of Alzheimer’s disease//Am J Epidemiol 1994; 140: 256-61.][Doren M., Schneider H.P.G. The Impact of Different HRT Regimes on Compliance//Int J Fertility 1995; 41 (1): 29-39.][Moyer D.L., et al. Prevention of endometrial hyperplasia by progesterone during long - term estradiol replacement: influence of bleeding pattern and secretory changes//Fertil Steril 1993; 59: 992-7.][Woodruff J.D. and Pickar. J.H. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogenes alone. Am J Obst Gynаec 1994; 170: 1213-23.][Sturdel D.W. et al. Is the timing of withdrawal bleeding a guide to endometrial safety during seguential replaicement therapy?//Lancet 1994; 344 (8928): 979-82.][Persson I. Epidemiology - hormone replacement therapy and the neoplasia//Int Proceeding J 1989; 1 (1): 140-3.]